A Case of Acute Myeloid Leukemia after Adalimumab Treatment in Psoriatic Arthritis
Journal of Rheumatic Diseases
; : 91-94, 2012.
Article
在 En
| WPRIM
| ID: wpr-15488
Responsible library:
WPRO
ABSTRACT
Hematologic malignancies and lymphoproliferative disorders have been reported after using tumor necrosis factor-alpha inhibitor in patients suffering from spondyloarthropathy. Previously reported cases were treated by using infliximab and etanercept. Usually, it takes approximately several months for leukemia or lymphoproliferative disorders to occur after the application of those agents. However, we report a case of acute myeloid leukemia that developed after short term usage of adalimumab in a patient suffering from psoriatic arthritis.
Key words
全文:
1
索引:
WPRIM
主要主题:
Stress, Psychological
/
Immunoglobulin G
/
Leukemia, Myeloid, Acute
/
Leukemia
/
Arthritis, Psoriatic
/
Tumor Necrosis Factor-alpha
/
Receptors, Tumor Necrosis Factor
/
Hematologic Neoplasms
/
Spondylarthropathies
/
Antibodies, Monoclonal, Humanized
限制:
Humans
语言:
En
期刊:
Journal of Rheumatic Diseases
年:
2012
类型:
Article